New Topol book envisions patient-centered digitalized care

The good old days of "doctor knows best" are as good as gone, according to Eric Topol, renowned cardiologist at Scripps Translational Science Institute, in his new book, "The Patient Will See You Now."

In a review of the book for New York Times, Abigal Zuger, MD, writes that the book summarizes pretty much all of the futuristic chatter of the past decade, with predictions about doctor visits via smartphone, the demise of hospitals and a streamlined approach to diagnoses.

Read more below:

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.